Genetic association of cytokines polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese

被引:0
作者
Thomas Pfeiffer
Ralph Feltens
Winfried Stoecker
机构
[1] Euroimmun Medical Laboratory diagnostic GmbH Leubeck Germany
[2] Euroimmun Medical Laboratory diagnostic GmbH Leubeck Germany
关键词
Autoimmune hepatitis; Primary biliary cirrhosis; Cytokine; Polymorphisms; Gene susceptibility;
D O I
暂无
中图分类号
R575 [肝及胆疾病];
学科分类号
1002 ; 100201 ;
摘要
AIM: To characterize gene polymorphism of several cytokine gene in-patients with AIH and PBC and to analyze the difference of the polymorphism distribution between Chinese patients and healthy controls. METHODS: The study population consisted of 62 patients with AIH, and 77 patients with PBC. The genetic profile of four cytokines was analyzed by restriction fragment length polymorphism after specific PCR amplification (PCR-RFLP) or sequence-specific primers PCR (SSP-PCR). The analyzed gene polymorphism included interleukin-1 (IL-1) (at position +3 953 and IL-1RN intron 2), IL-6 (at position -174), IL-10 promoter (at position -1082, -819, and -592). The control group consisted of 160 healthy blood donors. RESULTS: The majority of Chinese people including patients and healthy controls exhibited IL-1B 1,1 genotype, and there was no significant difference in AIH, PBC patients and controls. There were highly statistically significant differences in the distribution of the IL-1RN gene polymorphism between the patients with PBC compared with controls. The frequency of IL-1RN 1,1 was significantly higher (90.9% vs 79.4%, P=0.03) and the frequency of IL-1RN 1,2 was significantly lower in PBC patients (6.5% vs 17.5%, P=0.01). No statistical difference was observed between AIH patients and controls. All of the 160 healthy controls and 62 cases of AIH patients exhibited IL-6-174GG genotype, and there were four cases, which expressed IL-6-174GC genotype in 77 cases of PBC patients. The frequency of IL-6-174GC was markedly significantly higher in PBC patients compared with controls (5.2% vs 0%, P=0.004). No statistically significant difference was found in the distribution of IL-10 promoter genotype in AIH and PBC patients compared with controls. CONCLUSION: The polymorphisms of IL-1RN and IL-6-174G/C appear to be associated with PBC in Chinese patients.
引用
收藏
页码:2768 / 2772
页数:5
相关论文
共 19 条
  • [1] Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis. Czaja AJ,Cookson S,Constantini PK,Clare M,Underhill JA,Donaldson PT. Gastroenterology . 1999
  • [2] The role of cytokine polymorphisms in rejection after solid organ transplantation. Marshall SE,Welsh KI. Genes and Immunity . 2001
  • [3] Interleukin-10. Moore KW,O’Garra AO,de Waal Malefyt R,Vieira P,Mosmann TR. Annual Review of Immunology . 1993
  • [4] HLA and interleukin 1 gene polymorphisms in primary biliary cirrhosis:associations with disease progression and disease susceptibility. Donaldson P,Agarwal K,Craggs A,Craig W,James O,Jones D. Gut . 2001
  • [5] Family primary biliary cirrhosis reassessed:a geographicallybased population study. Jones DE,Watt FE,Metcalf JV,Bassendine MF,James OF. Journal of Hepatology . 1999
  • [6] Genetic association of tumor necrosis factor (TNF)-alpha polymorphisms with primary biliary cirrhosis and autoimmune liver diseases in a Chinese population. Fan LY,Zhong RQ,Tu XQ,Zhu Y,Feltens R,Pfeiffer T. Chinese Journal of Hepatology . 2004
  • [7] CTLA-4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris. Abrams JR,Lebwohl MG,Guzzo CA,Jagasothy BV,Goldfarb MT,Goffe BS. The Journal of Clinical Investigation . 1999
  • [8] Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism and susceptibility to type 1 autoimmune hepatitis. Agarwal K,Czaja AJ,Jones DE,Donaldson PT. Hepatology . 2000
  • [9] Human IL-10 is produced by clones and inhibits their antigen-specific proliferation and cytokine production. Del Prete GM,DeCarli F,Almerigogna MG,Giudizi MG,Biagiotti R,Romagnani S. J Immunol . 1993
  • [10] IL-6 ia an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. Xing Z,Gauldie J,Cox G,Baumann H,Jordana M,Lei XF,Achong MK. The Journal of Clinical Investigation . 1998